Valve in Valve transcatheter mitral valve replacement by a transvenous, transseptal access: A case report_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

WEI Jiafu ¹ , CHEN Fei ¹ , MENG Wei ² , WEI Xin ¹ , PENG Yong ¹ , LI Qiao ¹ , HE Sen ¹ , LI Yijian ¹ , ZHENG Mingxia ¹ , ZHOU Xuan ³ , CHEN Guo ⁴ ,  FENG Yuan ¹ ,  CHEN Mao ¹

1. Department of Vasculocardiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
2. Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
3. Department of Radiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
4. Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding author：

FENG Yuan, Email: fynotebook@hotmail.com; CHEN Mao, Email: hmaochen@vip.sina.com

Keywords：

Mitral valve replacement; transseptal; transvenous; transcatheter; Valve-in-Valve

DOI：

10.7507/1007-4848.202012088

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Reoperation due to degenerated bioprostheses is an important factor of high-risk thoracic surgeries. In 2020 ACC/AHA guideline, Valve in Valve (ViV) was recommended for high-risk patient instead of surgical mitral valve replacement. This report described a 77-year-old male patient with a failed mitral bioprosthetic valve, evaluated at high risk of surgery, received a transvenous, transseptal transcatheter mitral valve replacement (TMVR). Tracheal intubation was removed at CCU 3 h after surgery without discomfort such as polypnea. The patient was transferred out of the CCU and discharged on the 3rd day. Compared with transapical access, transvenous transseptal access was less invasive, with shorter duration in CCU and hospitalization.

Citation： WEI Jiafu, CHEN Fei, MENG Wei, WEI Xin, PENG Yong, LI Qiao, HE Sen, LI Yijian, ZHENG Mingxia, ZHOU Xuan, CHEN Guo, FENG Yuan, CHEN Mao. Valve in Valve transcatheter mitral valve replacement by a transvenous, transseptal access: A case report. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(1): 122-124. doi: 10.7507/1007-4848.202012088 Copy

1.	Bapat V. Valve-in-valve apps: why and how they were developed and how to use them. EuroIntervention, 2014, 10(Suppl U): U44-U51.
2.	Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2020. [Epub ahead of print].
3.	Frerker C, Schmidt T, Schlüter M, et al. Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria. EuroIntervention, 2016, 12(12): 1520-1526.
4.	Prendergast BD, Baumgartner H, Delgado V, et al. Transcatheter heart valve interventions: where are we? Where are we going? Eur Heart J, 2019, 40(5): 422-440.
5.	Schäfer U, Bader R, Frerker C, et al. Balloon-expandable valves for degenerated mitral xenografts or failing surgical rings. EuroIntervention, 2014, 10(2): 260-268.
6.	Descoutures F, Himbert D, Maisano , et al. Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur J Cardiothorac Surg, 2013, 44(1): e8-e15.

1. Bapat V. Valve-in-valve apps: why and how they were developed and how to use them. EuroIntervention, 2014, 10(Suppl U): U44-U51.
2. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2020. [Epub ahead of print].
3. Frerker C, Schmidt T, Schlüter M, et al. Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria. EuroIntervention, 2016, 12(12): 1520-1526.
4. Prendergast BD, Baumgartner H, Delgado V, et al. Transcatheter heart valve interventions: where are we? Where are we going? Eur Heart J, 2019, 40(5): 422-440.
5. Schäfer U, Bader R, Frerker C, et al. Balloon-expandable valves for degenerated mitral xenografts or failing surgical rings. EuroIntervention, 2014, 10(2): 260-268.
6. Descoutures F, Himbert D, Maisano , et al. Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur J Cardiothorac Surg, 2013, 44(1): e8-e15.

Previous Article
Research progress on role of exosomes derived from different cells in hepatic stellate cells
Next Article
Choice of pectoralis fascia resection in breast cancer surgery

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Valve in Valve transcatheter mitral valve replacement by a transvenous, transseptal access: A case report

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content